Announced Fri, 8 May · 19:22 IST

Please find attached Intimation of Investor Conference Call for Q4FY26 & FY26

Board & Shareholder Meetings View source PDF

MANKIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.3%1-day move

₹2423.00

prior close

₹2423.10

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.9+0.0-0.1-0.6-2.3-0.9+1.5+3.4+3.1+6.5-5.3-2.0+3.4—

Up moveDown movePending

AI summary

Mankind Pharma has scheduled an investor earnings call for Wednesday, May 20, 2026 at 12:00 PM IST (duration 1 hour) via Zoom webinar. The call will discuss Q4 and full-year FY26 business performance and results. Senior management including Vice Chairman & MD Rajeev Juneja, CEO Sheetal Arora, COO Arjun Juneja, CFO Ashutosh Dhawan, and other key executives will represent the company. The filing is dated May 8, 2026 and made under SEBI Listing Regulations 30 & 51.

Likely market impact

The call provides an upcoming opportunity for investors to hear FY26 results and Q4 performance directly from management, which could influence sentiment ahead of the formal results announcement.